Cochrane Abstracts
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Comparison of First‐line Chemotherapy Including Escalated BEACOPP Versus Chemotherapy Including ABVD for People With Early Unfavourable or Advanced Stage Hodgkin Lymphoma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma_New_search_for_studies_and_content_updated__conclusions_changed_. Accessed 03 October 2023.
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma_New_search_for_studies_and_content_updated__conclusions_changed_. Accessed October 3, 2023.
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma_New_search_for_studies_and_content_updated__conclusions_changed_
Comparison of First‐line Chemotherapy Including Escalated BEACOPP Versus Chemotherapy Including ABVD for People With Early Unfavourable or Advanced Stage Hodgkin Lymphoma [Internet]. In: Cochrane Abstracts. [cited 2023 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma_New_search_for_studies_and_content_updated__conclusions_changed_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
ID - 433061
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma_New_search_for_studies_and_content_updated__conclusions_changed_
DB - Evidence Central
DP - Unbound Medicine
ER -
